EGFR and colorectal cancer: In this work, we investigated one of these possible mechanisms, showing that E2F2 could have a role not only in being a direct effector of miR-31 in the regulation of the colorectal cancer proliferation [22], but also in the resistance to treatment with anti-EGFR.